Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Bladder Cancer

Free Subscription 11.06.2018 1 Br J Radiol 1 Can Urol Assoc J 1 Cancer Biomark 1 Cancer Nurs 1 Clin Chim Acta 2 Eur Rev Med Pharmacol Sci 1 Front Physiol 1 J Biosci 1 J Urol 1 Mol Ther Nucleic Acids 1 Onco Targets Ther 2 Oncotarget 1 PLoS One 1 Radiother Oncol 1 Res Rep Urol 1 Retin Cases Brief Rep 1 Tissue Cell 1 Toxicol Lett 2 Urol Oncol 1 World J Urol

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

Br J Radiol

1. NAIK N, Lin M, Lin P
   Genitourinary involvement of lymphomas on FDG-PET.
   Br J Radiol. 2018;91:20170273.
   PubMed     Text format     Abstract available
   
   

   
   Can Urol Assoc J

2. FAIREY AS, Mclarty R
   Orthotopic bladder substitution for bladder cancer patients undergoing radical cystectomy: A call to action.
   Can Urol Assoc J. 2018;12:187.
   PubMed     Text format    
   
   

   
   Cancer Biomark

3. JIANG S, Tian F, Wang Q, Cheng W, et al
   High expression of spindle and kinetochore- associated protein 1 predicts early recurrence and progression of non-muscle invasive bladder cancer.
   Cancer Biomark. 2018 May 25. pii: CBM181202. doi: 10.3233/CBM-181202.
   PubMed     Text format     Abstract available
   
   

   
   Cancer Nurs

4. JUNG A, Nielsen ME, Crandell JL, Palmer MH, et al
   Quality of Life in Non-Muscle-Invasive Bladder Cancer Survivors: A Systematic Review.
   Cancer Nurs. 2018 Jun 1. doi: 10.1097/NCC.0000000000000606.
   PubMed     Text format     Abstract available
   
   

   
   Clin Chim Acta

5. YU Y, Cao H, Zhang M, Shi F, et al
   Prognostic value of DNA methylation for bladder cancer.
   Clin Chim Acta. 2018;484:207-212.
   PubMed     Text format     Abstract available
   
   

   
   Eur Rev Med Pharmacol Sci

6. RAJWA P, Zyczkowski M, Paradysz A, Bujak K, et al
   Evaluation of the prognostic value of LMR, PLR, NLR, and dNLR in urothelial bladder cancer patients treated with radical cystectomy.
   Eur Rev Med Pharmacol Sci. 2018;22:3027-3037.
   PubMed     Text format     Abstract available
   
   
7. DONG ZC, Zhang D, Wang SB, Lin ZQ, et al
   Target inhibition on GSK-3beta by miR-9 to modulate proliferation and apoptosis of bladder cancer cells.
   Eur Rev Med Pharmacol Sci. 2018;22:3018-3026.
   PubMed     Text format     Abstract available
   
   

   
   Front Physiol

8. WEBER L, Schulz WA, Philippou S, Eckardt J, et al
   Characterization of the Olfactory Receptor OR10H1 in Human Urinary Bladder Cancer.
   Front Physiol. 2018;9:456.
   PubMed     Text format     Abstract available
   
   

   
   J Biosci

9. ZHU Y, Liang S, Pan H, Cheng Z, et al
   Inhibition of miR-1247 on cell proliferation and invasion in bladder cancer through its downstream target of RAB36.
   J Biosci. 2018;43:365-373.
   PubMed     Text format     Abstract available
   
   

   
   J Urol

10. AUDENET F, Waingankar N, Ferket BS, Niglio SA, et al
    Effectiveness of transurethral resection (TUR) plus systemic chemotherapy as definitive treatment for muscle-invasive bladder cancer (MIBC) in population-level data.
    J Urol. 2018 Jun 4. pii: S0022-5347(18)43313-7. doi: 10.1016/j.juro.2018.
    PubMed     Text format     Abstract available
    
    

    
    Mol Ther Nucleic Acids

11. JIN H, Sun W, Zhang Y, Yan H, et al
    MicroRNA-411 Downregulation Enhances Tumor Growth by Upregulating MLLT11 Expression in Human Bladder Cancer.
    Mol Ther Nucleic Acids. 2018;11:312-322.
    PubMed     Text format     Abstract available
    
    

    
    Onco Targets Ther

12. LI D, Hao X, Song Y
    An integrated analysis of key microRNAs, regulatory pathways and clinical relevance in bladder cancer.
    Onco Targets Ther. 2018;11:3075-3085.
    PubMed     Text format     Abstract available
    
    

    
    Oncotarget

13. WU SQ, Xu R, Li XF, Zhao XK, et al
    Prognostic roles of tumor associated macrophages in bladder cancer: a system review and meta-analysis.
    Oncotarget. 2018;9:25294-25303.
    PubMed     Text format     Abstract available
    
    
14. SNELL KIE, Ward DG, Gordon NS, Goldsmith JC, et al
    Exploring the roles of urinary HAI-1, EpCAM & EGFR in bladder cancer prognosis & risk stratification.
    Oncotarget. 2018;9:25244-25253.
    PubMed     Text format     Abstract available
    
    

    
    PLoS One

15. XIA Y, Liu Z, Yu W, Zhou S, et al
    The prognostic significance of long noncoding RNAs in bladder cancer: A meta-analysis.
    PLoS One. 2018;13:e0198602.
    PubMed     Text format     Abstract available
    
    

    
    Radiother Oncol

16. CHRISTODOULOU M, Reeves KJ, Hodgson C, Zeniou A, et al
    Outcomes of radiosensitisation in elderly patients with advanced bladder cancer.
    Radiother Oncol. 2018 Jun 2. pii: S0167-8140(18)30281.
    PubMed     Text format     Abstract available
    
    

    
    Res Rep Urol

17. MEKAYTEN M, Yutkin V, Duvdevani M, Pode D, et al
    High frequency of bladder cancer after nephroureterectomy: justification for adjuvant intravesical treatment?
    Res Rep Urol. 2018;10:33-38.
    PubMed     Text format     Abstract available
    
    

    
    Retin Cases Brief Rep

18. WHALEN KE, Eagle RC Jr, Vrabec TR
    CASE OF METASTATIC UROTHELIAL CARCINOMA OF THE RETINA AND VITREOUS.
    Retin Cases Brief Rep. 2018;12:177-180.
    PubMed     Text format     Abstract available
    
    

    
    Tissue Cell

19. DIAS LP, Luzo ACM, Volpe BB, Duran M, et al
    Effects of intravesical therapy with platelet-rich plasma (PRP) and Bacillus Calmette-Guerin (BCG) in non-muscle invasive bladder cancer.
    Tissue Cell. 2018;52:17-27.
    PubMed     Text format     Abstract available
    
    

    
    Toxicol Lett

20. HUANG CY, Lin YC, Shiue HS, Chen WJ, et al
    Comparison of Arsenic Methylation Capacity and Polymorphisms of Arsenic Methylation Genes between Bladder Cancer and Upper Tract Urothelial Carcinoma.
    Toxicol Lett. 2018 May 30. pii: S0378-4274(18)30231.
    PubMed     Text format     Abstract available
    
    

    
    Urol Oncol

21. DANESHMAND S, Bazargani ST, Bivalacqua TJ, Holzbeierlein JM, et al
    Blue light cystoscopy for the diagnosis of bladder cancer: Results from the US prospective multicenter registry.
    Urol Oncol. 2018 May 30. pii: S1078-1439(18)30135.
    PubMed     Text format     Abstract available
    
    
22. YANG GL, Zhang LH, Liu Q, Wang ZL, et al
    Commentary on "A novel treatment strategy for newly diagnosed high-grade T1 bladder cancer: Gemcitabine and cisplatin adjuvant chemotherapy-A single-institution experience."
    Urol Oncol. 2018 May 30. pii: S1078-1439(18)30164.
    PubMed     Text format     Abstract available
    
    

    
    World J Urol

23. AUDENET F, Farkas AM, Anastos H, Galsky MD, et al
    Immune phenotype of peripheral blood mononuclear cells in patients with high-risk non-muscle invasive bladder cancer.
    World J Urol. 2018 Jun 2. pii: 10.1007/s00345-018-2359.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Bladder Cancer is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: